Patient no. | Histology | Grade | ER/PR | HER2 IHCa | HER2 copies | HER2/CEP17 ratio | Intrinsic subtype | TNM stage | Herceptin ± chemo given? | NAT, AT, MET | Herceptin ± chemo regimenb | If NAT, pathologic response? | Follow-up timec | Disease status |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | IDC | 3 | +/+ | + 3 | 19.1 | 5.8 | NS | pT1cN0 | No; patient declined | N/A | N/A | N/A | 9 months | Remission |
2 | IMPC | 2 | −/− | + 3 | 17.6 | 4.8 | NS | pT1bNx | No; not offered 2/2 age/comorbidities | N/A | N/A | N/A | 4 months | Died of AAA rupture |
3 | IDC | 3 | +/+ | + 3 | 20.6 | 6.6 | Luminal A | cT2N1M0 | Yes | NAT & AT | NAT: T-DM1 + P on a trial, AT: THP | PR | 25 months | Remission |
4 | IDC | 3 | +/+ | + 3 | > 10 | 5.2 | HER2-E | cT1cN0 | Yes | NAT & AT | NAT: T-DM1 + P on a trial, then AT: docetaxel ×4 cycles + H ×1 year | CR | 12 months | Remission |
5 | IDC | 3 | −/− | + 3 | > 20 | 1.0d | HER2-E | cT1cN0 | Yes | NAT | THP | CR | 18 months | Remission |
6 | IDC | 2 | −/− | + 3 | 12.8 | 5.4 | NS | cT2-3 N1 | Yes | NAT | THP-ddAC | PR | 5 months | Remission |
7 | IDC | 3 | −/− | + 3 | 23.3 | 5.3 | HER2-E | cT2N0 | na | na | Na | na | na | na |
8 | IDC | 3 | −/− | + 3 | 20.7 | 6.4 | NS | pT1cNx | Yes | AT | TH | N/A | 27 months | Remission |
9 | ILC | 2 | −/− | + 3 | > 6 | 5.6 | NS | pT1aN0 | Yes | AT | TH | N/A | 25 months | Remission |
10 | IDC | 3 | −/− | + 3 | 26.3 | 7.6 | HER2-E | pT1bN0 | Yes | AT | TH | N/A | 30 months | Remission |
11 | IDC | 3 | −/− | + 3 | > 10 | > 3.8 | HER2-E | pT1bN0 | Yes | AT | TH | N/A | 21 months | Remission |
12 | IMPC | 3 | −/− | + 3 | 19.85 | 7.4 | HER2-E | pT1cN1a | Yes | AT | ddAC-TH | N/A | 28 months | Remission |
13 | IDC | 2 | +/− | + 3 | 37.2 | 6.8 | NS | pT1bN0 | Yes | AT | ddAC-TH | N/A | 26 months | Remission |
14 | IDC | 3 | +/− | + 3 | 6.88 | 3.2 | NS | pT2N1a | Yes | AT | THP ×12 weeks, ddACX2 (stopped 2/2 SAE, 1 year H) | N/A | 22 months | Remission |
15 | IDC | 3 | +/− | + 3 | > 20 | 9.5 | NS | pT1aN0 | Yes | AT | T-DM1 on a trial | N/A | 20 months | Remission |
16 | IDC | 3 | +/− | + 3 | 23 | 8.1 | HER2-E | pT1bN1a | Yes | AT | ddAC-THP | N/A | 17 months | Remission |
17 | IDC | 3 | +/+ | + 3 | > 10 | 3 | NS | T2N1M1b | Yes | MET | THP, AC, various | N/A | 35 months | Alive, on tx |
18 | IDC | 3 | −/− | + 3 | 26.7 | 9.4 | HER2-E | na | na | na | na | na | na | na |
19 | IDC | 2 | +/− | + 3 | 20.3 | 3.4 | NS | cT3N1 | na | na | na | na | na | na |